• Je něco špatně v tomto záznamu ?

High Prevalence of Growth Plate Gene Variants in Children With Familial Short Stature Treated With GH

L. Plachy, V. Strakova, L. Elblova, B. Obermannova, S. Kolouskova, M. Snajderova, D. Zemkova, P. Dusatkova, Z. Sumnik, J. Lebl, S. Pruhova,

. 2019 ; 104 (10) : 4273-4281. [pub] 20191001

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc20023635

Grantová podpora
NV16-31211A MZ0 CEP - Centrální evidence projektů

Digitální knihovna NLK
Plný text - Článek

E-zdroje Online Plný text

NLK Free Medical Journals od 1997 do Před 1 rokem
ProQuest Central od 2017-01-01 do 2020-12-31
Health & Medicine (ProQuest) od 2017-01-01 do 2020-12-31

CONTEXT: Familial short stature (FSS) is a term describing a growth disorder that is vertically transmitted. Milder forms may result from the combined effect of multiple genes; more severe short stature is suggestive of a monogenic condition. The etiology of most FSS cases has not been thoroughly elucidated to date. OBJECTIVES: To identify the genetic etiology of severe FSS in children treated with GH because of the diagnosis of small for gestational age or GH deficiency (SGA/GHD). DESIGN, SETTINGS, AND PATIENTS: Of 736 children treated with GH because of GHD/SGA, 33 with severe FSS (life-minimum height -2.5 SD or less in both the patient and shorter parent) were included in the study. The genetic etiology was known in 5 of 33 children prior to the study [ACAN (in 2], NF1, PTPN11, and SOS1). In the remaining 28 of 33, whole-exome sequencing was performed. The results were evaluated using American College of Medical Genetics and Genomics standards and guidelines. RESULTS: In 30 of 33 children (90%), we found at least one variant with potential clinical significance in genes known to affect growth. A genetic cause was elucidated in 17 of 33 (52%). Of these children, variants in growth plate-related genes were found in 9 of 17 [COL2A1, COL11A1, and ACAN (all in 2), FLNB, FGFR3, and IGF1R], and IGF-associated proteins were affected in 2 of 17 (IGFALS and HMGA2). In the remaining 6 of 17, the discovered genetic mechanisms were miscellaneous (TRHR, MBTPS2, GHSR, NF1, PTPN11, and SOS1). CONCLUSIONS: Single-gene variants are frequent among families with severe FSS, with variants affecting the growth plate being the most prevalent.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20023635
003      
CZ-PrNML
005      
20201214130654.0
007      
ta
008      
201125s2019 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1210/jc.2018-02288 $2 doi
035    __
$a (PubMed)30753492
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Plachy, Lukas $u Department of Pediatrics, 2nd Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. University Hospital Motol, Prague 5, Czech Republic.
245    10
$a High Prevalence of Growth Plate Gene Variants in Children With Familial Short Stature Treated With GH / $c L. Plachy, V. Strakova, L. Elblova, B. Obermannova, S. Kolouskova, M. Snajderova, D. Zemkova, P. Dusatkova, Z. Sumnik, J. Lebl, S. Pruhova,
520    9_
$a CONTEXT: Familial short stature (FSS) is a term describing a growth disorder that is vertically transmitted. Milder forms may result from the combined effect of multiple genes; more severe short stature is suggestive of a monogenic condition. The etiology of most FSS cases has not been thoroughly elucidated to date. OBJECTIVES: To identify the genetic etiology of severe FSS in children treated with GH because of the diagnosis of small for gestational age or GH deficiency (SGA/GHD). DESIGN, SETTINGS, AND PATIENTS: Of 736 children treated with GH because of GHD/SGA, 33 with severe FSS (life-minimum height -2.5 SD or less in both the patient and shorter parent) were included in the study. The genetic etiology was known in 5 of 33 children prior to the study [ACAN (in 2], NF1, PTPN11, and SOS1). In the remaining 28 of 33, whole-exome sequencing was performed. The results were evaluated using American College of Medical Genetics and Genomics standards and guidelines. RESULTS: In 30 of 33 children (90%), we found at least one variant with potential clinical significance in genes known to affect growth. A genetic cause was elucidated in 17 of 33 (52%). Of these children, variants in growth plate-related genes were found in 9 of 17 [COL2A1, COL11A1, and ACAN (all in 2), FLNB, FGFR3, and IGF1R], and IGF-associated proteins were affected in 2 of 17 (IGFALS and HMGA2). In the remaining 6 of 17, the discovered genetic mechanisms were miscellaneous (TRHR, MBTPS2, GHSR, NF1, PTPN11, and SOS1). CONCLUSIONS: Single-gene variants are frequent among families with severe FSS, with variants affecting the growth plate being the most prevalent.
650    _2
$a mladiství $7 D000293
650    _2
$a dítě $7 D002648
650    _2
$a předškolní dítě $7 D002675
650    _2
$a kohortové studie $7 D015331
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a genetická predispozice k nemoci $x epidemiologie $7 D020022
650    12
$a genetická variace $7 D014644
650    _2
$a poruchy růstu $x farmakoterapie $x epidemiologie $x genetika $7 D006130
650    _2
$a růstová ploténka $x účinky léků $7 D006132
650    _2
$a lidský růstový hormon $x terapeutické užití $7 D019382
650    _2
$a lidé $7 D006801
650    _2
$a kojenec $7 D007223
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a metaloendopeptidasy $x genetika $7 D008666
650    _2
$a rodokmen $7 D010375
650    _2
$a prognóza $7 D011379
650    _2
$a prospektivní studie $7 D011446
650    _2
$a receptor fibroblastových růstových faktorů, typ 3 $x genetika $7 D051498
650    _2
$a receptor IGF typ 1 $x genetika $7 D017526
650    _2
$a stupeň závažnosti nemoci $7 D012720
650    _2
$a výsledek terapie $7 D016896
650    _2
$a sekvenování exomu $x metody $7 D000073359
651    _2
$a Česká republika $7 D018153
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Strakova, Veronika $u Department of Pediatrics, 2nd Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. University Hospital Motol, Prague 5, Czech Republic.
700    1_
$a Elblova, Lenka $u Department of Pediatrics, 2nd Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. University Hospital Motol, Prague 5, Czech Republic.
700    1_
$a Obermannova, Barbora $u Department of Pediatrics, 2nd Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. University Hospital Motol, Prague 5, Czech Republic.
700    1_
$a Kolouskova, Stanislava $u Department of Pediatrics, 2nd Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. University Hospital Motol, Prague 5, Czech Republic.
700    1_
$a Snajderova, Marta $u Department of Pediatrics, 2nd Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. University Hospital Motol, Prague 5, Czech Republic.
700    1_
$a Zemkova, Dana $u Department of Pediatrics, 2nd Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. University Hospital Motol, Prague 5, Czech Republic.
700    1_
$a Dusatkova, Petra $u Department of Pediatrics, 2nd Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. University Hospital Motol, Prague 5, Czech Republic.
700    1_
$a Sumnik, Zdenek $u Department of Pediatrics, 2nd Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. University Hospital Motol, Prague 5, Czech Republic.
700    1_
$a Lebl, Jan $u Department of Pediatrics, 2nd Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. University Hospital Motol, Prague 5, Czech Republic.
700    1_
$a Pruhova, Stepanka $u Department of Pediatrics, 2nd Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. University Hospital Motol, Prague 5, Czech Republic.
773    0_
$w MED00002582 $t The Journal of clinical endocrinology and metabolism $x 1945-7197 $g Roč. 104, č. 10 (2019), s. 4273-4281
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30753492 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201214130653 $b ABA008
999    __
$a ok $b bmc $g 1595954 $s 1114311
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 104 $c 10 $d 4273-4281 $e 20191001 $i 1945-7197 $m The Journal of clinical endocrinology and metabolism $n J Clin Endocrinol Metab $x MED00002582
GRA    __
$a NV16-31211A $p MZ0
LZP    __
$a Pubmed-20201125

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...